For the past 8-months now our team has been long La Jolla Pharmaceuticals (Nasdaq: LJPC) calling for a substantial upside in the stock price. At times our thesis has played out such as with the … [Read more...] about La Jolla Pharmaceuticals (Nasdaq: LJPC): An Assessment of The Tetraphase Acquisition
Articles
Readers’ Choice: Verastem Oncology (NASDAQ: VSTM)
You spoke and we listened! The winner of the Reader's Choice article was Verastem Oncology (VSTM). After the brief summary provided, you voted for a full report on Verastem, which is included in this … [Read more...] about Readers’ Choice: Verastem Oncology (NASDAQ: VSTM)
DelMar Pharmaceuticals (NASDAQ: DMPI): A New Beginning
For the past 6-months our team at MS Money Moves has been following the story of DelMar Pharmaceuticals (NASDAQ: DMPI) in an effort to educate and inform the investment community. During this time, we … [Read more...] about DelMar Pharmaceuticals (NASDAQ: DMPI): A New Beginning
BioCryst (NASDAQ: BCRX): Beyond Galidesivir
BioCryst Pharmaceuticals (NASDAQ: BCRX) is a mid-cap biotechnology company that is developing medications on two main areas of focus, and has one commercialized medications. The two main areas … [Read more...] about BioCryst (NASDAQ: BCRX): Beyond Galidesivir
Reader’s Choice: New Institutional Buys 1Q2020
Here at MS Money Moves, we seek to provide the research edge that retail investors need in order to be successful in these volatile markets. One thing we know in the world of investing in … [Read more...] about Reader’s Choice: New Institutional Buys 1Q2020
LJPC and BCRX Updates: 5/27/20
5/27/20 was the worst day for our team since March 13th when almost every stock on the market was halted due to volatility. Our two largest positions, La Jolla Pharmaceuticals (Nasdaq: LJPC) and … [Read more...] about LJPC and BCRX Updates: 5/27/20
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish